Bethesda, MD — New research into the mechanisms underlying myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and long COVID is aimed at identifying potential approaches to treatment of the ...

The Solve ME/CFS Catalyst Award-winning studies will fast-track clinical and immunological studies aimed at delivering new treatment strategies and diagnostic insights for ME/CFS and Long Covid, ...

An estimated two million people in England and Scotland were experiencing symptoms of long COVID as of March 2024, according to the Office for National Statistics. Of these, 1.5 million said the ...

A study led by UMass Chan Medical School viral immunologists Liisa Selin, MD, Ph.D., and Anna Gil, Ph.D., discovered similarities in immune system dysfunction as a potential biomarker among people ...

On Monday, September 19, 2022, #MeAction Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and long COVID activists protested to address the crisis in the country with post-viral diseases.

People who suffer from the condition known as chronic fatigue syndrome are accustomed to being dismissed by health care professionals and to only occasional mentions of their condition in the media.

Elizabeth Ansell transformed her chronic fatigue syndrome diagnosis into advocacy that secured congressional recognition and NIH funding for the overlooked disease.

On Monday, September 19, 2022, #MeAction Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and long COVID activists protested to address the crisis in the country with post-viral diseases.